1-CTLA-4 “Cytotoxic T-lymphocyte associated protein 4, (CTLA-4) yada CD152” blockade
İpilimumab
2-PD-1” Programmed cell death protein 1 (PD-1)” inhibitors
Pembrolizumab (Keytruda, lambrolizumab)
Nivolumab (Opdivo).
Cemiplimab (Libtayo).
Dostarlimab (Jemperli)
Retifanlimab (Zynyz)
Toripalimab (Loqtorzi)
Tislelizumab (Tevimbra)
Vopratelimab
Spartalizumab
Camrelizumab
3-PD-L1 “Programmed death-ligand 1 (PD-L1) yani CD274 “ inhibitors
Atezolizumab (Tecentriq)
Avelumab (Bavencio)
Durvalumab (Imfinzi)
Cosibelimab (Unloxcyt)
4-CISH “Cytokine-inducible SH2-containing protein”:
5-Combinations
Ruxolitinib ve nivolumab